Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Antivirals Shown Effective Against H1N1 In Animal Trial

This article was originally published in PharmAsia News

Executive Summary

A pair of antivirals being developed by Japanese drug makers have shown to be effective against the H1N1 virus, according to scientists in a published study. The University of Tokyo, and the University of Wisconsin in the United States conducted studies on drugs still under development by Daiichi Sankyo and Toyama Chemical. Daiichi Sankyo's CS-8958 and Toyama's T-705, each in clinical trials, were tested on animals and found to lower virus levels by a considerable amount. Toyama's drug works by inhibiting the RNA polymerase protein while Daiichi Sankyo's is similar to the two major flu antivirals. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts